| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
6 |
/ |
2022 |
|
|
|
| |
Data sporządzenia: |
2022-07-07 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing Sales of CompuFlo Epidural disposables to a leading medical center in Southern
California
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that following a successful trial and evaluation, it has commenced
sales of its CompuFlo Epidural disposables to a leading medical center in Southern
California, which has been designated as one of the America's Best Maternity Care
Hospitals 2022 by Newsweek. This medical center also belongs to one of the nation's
largest not-for-profit healthcare systems serving over 10 million members, with more
than 100,000 babies delivered each year across multiple states. The name of the hospital
cannot be disclosed for confidentiality reasons.
The Board of Directors of the Company is honored to have been approved as a vendor
to commence sales of CompuFlo Epidural disposables within a leading medical center
in Southern California. The addition of this hospital illustrates the continued traction
in the labor and delivery market across the country, and further validates the favorable
response to our technology by leading anesthesiologists.
|
|
|